Li Zhang

research group of jian gong on pharmacoepidemiology and clinical drug evaluation

H指数:33

被引数:3,032

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database

BTK抑制剂的世代安全性特征：不良事件信号及来自FAERS数据库的真实世界证据

Frontiers in Medicine

IF3

2026-09-040

Mitochondrial characteristics of echinocandin tolerance and resistance in Candida glabrata and Candida krusei

棘白菌素耐受和耐药性在光滑念珠菌和克柔念珠菌中的线粒体特征

Frontiers in Microbiology

IF4.5

2026-07-270

OAAI

Age-Dependent Variations in the Distribution of Aeromonas Species in Human Enteric Infections

PATHOGENS

IF3.3

2025-01-280

OAAI

Human macrophage response to the emerging enteric pathogen Aeromonas veronii: Inflammation, apoptosis, and downregulation of histones

VIRULENCE

IF5.4

2024-12-280

OAAI

FpPEX5 and FpPEX7 are involved in the growth, reproduction, DON toxin production, and pathogenicity in Fusarium pseudograminearum

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-06-010

PRE

Analysis of global Aeromonas caviae genomes revealed that strains carrying T6SS are more common in human gastroenteritis than in environmental sources and are often phylogenetically related

MICROBIAL GENOMICS

IF4

2024-05-301

OAAI

Uncovering the boundaries of Campylobacter species through large-scale phylogenetic and nucleotide identity analyses

MSYSTEMS

IF4.6

2024-04-162

OAAI

Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-04-010

PRE

Investigation of Campylobacter concisus gastric epithelial pathogenicity using AGS cells

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-01-111

OAAI

Clinical Setting Comparative Analysis of Uropathogens and Antibiotic Resistance: A Retrospective Study Spanning the Coronavirus Disease 2019 Pandemic

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2023-12-220

OAAI

Emerging Aeromonas enteric infections: their association with inflammatory bowel disease and novel pathogenic mechanisms

MICROBIOLOGY SPECTRUM

IF3.8

2023-10-178

OAAI

Enteric Aeromonas Infection: a Common Enteric Bacterial Infection with a Novel Infection Pattern Detected in an Australian Population with Gastroenteritis

MICROBIOLOGY SPECTRUM

IF3.8

2023-08-177

OAAI

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2023-03-022

OAAI

Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-03-0118

PRE

Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus

FRONTIERS IN MEDICINE

IF3

2021-11-087

OAAI

Campylobacter concisus upregulates PD-L1 mRNA expression in IFN-γ sensitized intestinal epithelial cells and induces cell death in esophageal epithelial cells

JOURNAL OF ORAL MICROBIOLOGY

IF5.5

2021-09-145

OAAI

Analysis of complete Campylobacter concisus genomes identifies genomospecies features, secretion systems and novel plasmids and their association with severe ulcerative colitis

MICROBIAL GENOMICS

IF4

2020-11-0116

OAAI

Analyses of energy metabolism and stress defence provide insights into Campylobacter concisus growth and pathogenicity

对能量代谢和应激防御的分析提供了对弯曲杆菌生长和致病性的见解

GUT PATHOGENS

IF4

2020-03-059

OAAI

Effects of Anti-Cytokine Antibodies on Gut Barrier Function

MEDIATORS OF INFLAMMATION

IF4.2

2019-11-1213

OAAI

Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation

囊性纤维化跨膜传导调节因子调节肠胆碱能活动，并在慢传输型便秘患者的肠神经节中异常表达

JOURNAL OF GASTROENTEROLOGY

IF5.5

2019-08-0713

PREAI

Li Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向